The U.S. government will pay vaccine maker Moderna $176 million to increase the development of a pandemic influenza vaccine that could be used to treat bird flu in people, federal officials announced on Tuesday.
Categories: $176 million12 states130 herds20232025antiviralsBARDABiomedical Advanced Research and Development AuthorityBird FluBusinessCOVID-19 vaccinesdairy cowsearly study resultsearly-stage testingfarm workersfederal officialsHHS officialshumansinfected cowsJames MeyersJULYlate-stage trialmedical treatmentsModernamRNA technologyOAN Newsroompandemic influenza vaccinePeoplepotential pandemicsTechTECHNOLOGYTodays HeadlinestuesdayU.S.U.S. Department of Health and Human ServicesU.S. governmentvaccine makervirus